170 related articles for article (PubMed ID: 28734853)
1. The impact of MK-467 on sedation, heart rate and arterial blood pressure after intramuscular coadministration with dexmedetomidine in conscious cats.
Honkavaara J; Pypendop B; Ilkiw J
Vet Anaesth Analg; 2017 Jul; 44(4):811-822. PubMed ID: 28734853
[TBL] [Abstract][Full Text] [Related]
2. The effect of MK-467, a peripheral α
Honkavaara J; Pypendop B; Turunen H; Ilkiw J
Vet Anaesth Analg; 2017 Jan; 44(1):42-51. PubMed ID: 28237683
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic effects of dexmedetomidine, with and without MK-467, following intramuscular administration in cats anesthetized with isoflurane.
Siao KT; Pypendop BH; Honkavaara J; Ilkiw JE
Vet Anaesth Analg; 2017 Sep; 44(5):1101-1115. PubMed ID: 29056418
[TBL] [Abstract][Full Text] [Related]
4. The effects of increasing doses of MK-467, a peripheral alpha(2)-adrenergic receptor antagonist, on the cardiopulmonary effects of intravenous dexmedetomidine in conscious dogs.
Honkavaara JM; Restitutti F; Raekallio MR; Kuusela EK; Vainio OM
J Vet Pharmacol Ther; 2011 Aug; 34(4):332-7. PubMed ID: 20969603
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of dexmedetomidine, MK-467 and their combination following intramuscular administration in male cats.
Pypendop BH; Honkavaara J; Ilkiw JE
Vet Anaesth Analg; 2017 Jul; 44(4):823-831. PubMed ID: 28663042
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular and sedation reversal effects of intramuscular administration of atipamezole in dogs treated with medetomidine hydrochloride with or without the peripheral α
Turunen H; Raekallio MR; Honkavaara JM; Restitutti F; Kallio-Kujala IJ; Adam M; Nevanperä K; Scheinin M; Männikkö SK; Hautajärvi HJ; Larenza Menzies P; Vainio OM
Am J Vet Res; 2019 Oct; 80(10):912-922. PubMed ID: 31556714
[TBL] [Abstract][Full Text] [Related]
7. Plasma concentration and cardiovascular effects of intramuscular medetomidine combined with three doses of the peripheral alpha
Restitutti F; Kaartinen MJ; Raekallio MR; Wejberg O; Mikkola E; Del Castillo JRE; Scheinin M; Vainio OM
Vet Anaesth Analg; 2017 May; 44(3):417-426. PubMed ID: 28552594
[TBL] [Abstract][Full Text] [Related]
8. Peripheral α
Kallio-Kujala IJ; Raekallio MR; Honkavaara J; Bennett RC; Turunen H; Scheinin M; Hautajärvi H; Vainio O
Vet Anaesth Analg; 2018 Jul; 45(4):405-413. PubMed ID: 29891212
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular effects of dexmedetomidine, with or without MK-467, following intravenous administration in cats.
Pypendop BH; Honkavaara J; Ilkiw JE
Vet Anaesth Analg; 2017 Jan; 44(1):52-62. PubMed ID: 27377604
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular, respiratory and sedative effects of intramuscular alfaxalone, butorphanol and dexmedetomidine compared with ketamine, butorphanol and dexmedetomidine in healthy cats.
Cremer J; Riccó CH
J Feline Med Surg; 2018 Oct; 20(10):973-979. PubMed ID: 29192545
[TBL] [Abstract][Full Text] [Related]
11. Sedative, cardiovascular, haematologic and biochemical effects of four different drug combinations administered intramuscularly in cats.
Biermann K; Hungerbühler S; Mischke R; Kästner SB
Vet Anaesth Analg; 2012 Mar; 39(2):137-50. PubMed ID: 22356415
[TBL] [Abstract][Full Text] [Related]
12. The impact of MK-467 on plasma drug concentrations, sedation and cardiopulmonary changes in sheep treated with intramuscular medetomidine and atipamezole for reversal.
Adam M; Raekallio MR; Keskitalo T; Honkavaara JM; Scheinin M; Kajula M; Mölsä S; Vainio OM
J Vet Pharmacol Ther; 2018 Jun; 41(3):447-456. PubMed ID: 29352473
[TBL] [Abstract][Full Text] [Related]
13. The cardiopulmonary effects of a peripheral alpha-2-adrenoceptor antagonist, MK-467, in dogs sedated with a combination of medetomidine and butorphanol.
Salla K; Restitutti F; Vainionpää M; Junnila J; Honkavaara J; Kuusela E; Raekallio M; Vainio O
Vet Anaesth Analg; 2014 Nov; 41(6):567-74. PubMed ID: 24674053
[TBL] [Abstract][Full Text] [Related]
14. Cardiopulmonary and sedative effects of the peripheral α2-adrenoceptor antagonist MK 0467 administered intravenously or intramuscularly concurrently with medetomidine in dogs.
Rolfe NG; Kerr CL; McDonell WN
Am J Vet Res; 2012 May; 73(5):587-94. PubMed ID: 22533388
[TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy and cardiorespiratory effects of intramuscular administration of alfaxalone alone or in combination with dexmedetomidine in cats.
Rodrigo-Mocholí D; Belda E; Bosmans T; Laredo FG
Vet Anaesth Analg; 2016 May; 43(3):291-300. PubMed ID: 26459140
[TBL] [Abstract][Full Text] [Related]
16. Cardiopulmonary effects of dexmedetomidine, with and without vatinoxan, in isoflurane-anesthetized cats.
Jaeger AT; Pypendop BH; Ahokoivu H; Honkavaara J
Vet Anaesth Analg; 2019 Nov; 46(6):753-764. PubMed ID: 31416697
[TBL] [Abstract][Full Text] [Related]
17. Sedative effect of intramuscular medetomidine with and without vatinoxan (MK-467), and its reversal with atipamezole in sheep.
Adam M; Raekallio MR; Vainio OM
Vet Anaesth Analg; 2018 Nov; 45(6):788-793. PubMed ID: 30301665
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of dexmedetomidine, MK-467, and their combination following intravenous administration in male cats.
Pypendop BH; Honkavaara J; Ilkiw JE
J Vet Pharmacol Ther; 2016 Oct; 39(5):460-8. PubMed ID: 26896345
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the clinical efficacy and safety of dexmedetomidine or medetomidine in cats and their reversal with atipamezole.
Granholm M; McKusick BC; Westerholm FC; Aspegrén JC
Vet Anaesth Analg; 2006 Jul; 33(4):214-23. PubMed ID: 16764585
[TBL] [Abstract][Full Text] [Related]
20. Sedative and cardiovascular effects of intranasal or intramuscular dexmedetomidine in healthy dogs.
Micieli F; Santangelo B; Reynaud F; Mirra A; Napoleone G; Della Valle G; Portier KG; Vesce G
Vet Anaesth Analg; 2017 Jul; 44(4):703-709. PubMed ID: 28716686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
